Provention Bio

Provention Bio is a biopharmaceutical company based in Red Bank, New Jersey. The company employs 67 people and generates $2 million in annual revenue. Provention Bio develops investigational therapies designed to prevent debilitating and life-threatening immune-mediated diseases. Their focus is on early interception of autoimmune diseases before they cause irreversible damage to patients. Their lead product candidate is currently under review by the U.S. Food and Drug Administration (FDA) for the delay or prevention of type 1 diabetes in at-risk individuals. They also have additional clinical-stage product candidates for autoimmune diseases such as celiac disease and lupus. Provention Bio differentiates itself from traditional pharmaceutical companies by concentrating on early intervention in the disease process. To learn more about Provention Bio, visit their website at www.proventionbio.com. You can also connect with them on LinkedIn and Twitter (@ProventionBio).